Health Catalyst, Inc. (NASDAQ: HCAT) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $104M. The Maz Rating grades it against the other companies in its sector.
Health Catalyst, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.37, Health Catalyst, Inc. trades at 0.4x sales and 0.7x book value. Over the last twelve months it generated about $272M of revenue and a net loss of $215M. It runs a gross margin of 44.8%, an operating margin of -20.5% and a net margin of -74.2%. It shows return on equity of -128.2%, return on invested capital of -34.2% and a free cash flow yield of 24.6%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 1.70. Over the past 52 weeks the share price ranged from $0.95 to $3.03, with a beta of 1.53.
Health Catalyst, Inc. does not currently pay a dividend.
22 Wall Street analyst ratings cover the stock: 11 Buy and 11 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Health Catalyst, Inc. (HCAT) passes 1 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI, and fails AAOIFI, S&P Global, Dow Jones and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 63.8% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 63.8% / 33% · Receivables / Mkt Cap (36m) 33.4% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 63.8% / 33.33% · Receivables / Mkt Cap (24m) 33.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 30.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 25.6% / 33.33% · Receivables / Avg Assets (4Q) 13.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 33.3% / 33.33% · (Cash+Recv) / Total Assets 50.7% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Health Catalyst, Inc. (HCAT) passes 1 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI, and fails AAOIFI, S&P Global, Dow Jones and FTSE.
No. Health Catalyst, Inc. is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
Health Catalyst, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.